When the two dosages were analysed separately, the decrease in UPCR at nine months was statistically significant only for the 16 mg/day dose but of borderline significance for the lower dose (Fig. 2 ).
1
—
—
When the two dosages were analysed separately, the decrease in UPCR at nine months was statistically significant only for the 16 mg/day dose but of borderline significance for the lower dose (Fig. 2 ).